第 1 到 35 筆結果,共 35 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2020 | Landscape of mitochondria genome and clinical outcomes in stage 1 lung adenocarcinoma | Raghav L.; Chang Y.-H.; Hsu Y.-C.; Li Y.-C.; Chen C.-Y.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Chuang C.-Y.; Lee M.-H.; Wang C.-L.; HUEI-WEN CHEN ; SUNG-LIANG YU ; SHENG-FANG SU ; Yuan S.-S.; Chen J.J.W.; Ho S.-Y.; Li K.-C.; PAN-CHYR YANG ; Chang G.-C.; Chen H.-Y. | Cancers | 8 | 8 | |
2 | 2019 | High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patients | Hsu K.-H.; Huang Y.-H.; Tseng J.-S.; Chen K.-C.; Ku W.-H.; KANG-YI SU ; Chen J.J.W.; HUEI-WEN CHEN ; SUNG-LIANG YU ; Yang T.-Y.; Chang G.-C. | Lung Cancer | 64 | 52 | |
3 | 2017 | HOXA5 and p53 cooperate to suppress lung cancer cell invasion and serve as good prognostic factors in non-small cell lung cancer | Chang C.-J.; Chen Y.-L.; Hsieh C.-H.; Liu Y.-J.; SUNG-LIANG YU ; Chen J.J.W.; Wang C.-C. | Journal of Cancer | 33 | 33 | |
4 | 2017 | Cancer cells increase endothelial cell tube formation and survival by activating the PI3K/Akt signalling pathway | Cheng H.-W.; Chen Y.-F.; Wong J.-M.; Weng C.-W.; Chen H.-Y.; SUNG-LIANG YU ; HUEI-WEN CHEN ; ANG YUAN ; Chen J.J.W. | Journal of Experimental and Clinical Cancer Research | 101 | 92 | |
5 | 2016 | Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma | Su T.-J.; Ku W.-H.; Chen H.-Y.; Hsu Y.-C.; Hong Q.-S.; Chang G.-C.; SUNG-LIANG YU ; Chen J.J.W. | American Journal of Cancer Research | 22 | ||
6 | 2016 | HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms | Chen C.-H.; Chang W.-H.; KANG-YI SU ; Ku W.-H.; Chang G.-C.; Hong Q.-S.; Hsiao Y.-J.; Chen H.-C.; Chen H.-Y.; Wu R.; PAN-CHYR YANG ; Chen J.J.W.; SUNG-LIANG YU | Oncogene | 21 | 21 | |
7 | 2016 | Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients | Huang Y.-H.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; KANG-YI SU ; Chen H.-Y.; Chang C.-S.; Chen J.J.W.; SUNG-LIANG YU ; HUEI-WEN CHEN ; Yang T.-Y.; Chang G.-C. | Journal of Thoracic Disease | 2 | 2 | |
8 | 2016 | Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients | Hsu K.-H.; Tseng J.-S.; Wang C.-L.; Yang T.-Y.; Tseng C.-H.; Chen H.-Y.; Chen K.-C.; Tsai C.-R.; Yang C.-T.; SUNG-LIANG YU ; KANG-YI SU ; CHONG-JEN YU ; CHAO-CHI HO ; Hsia T.-C.; Wu M.-F.; Chiu K.-L.; Liu C.-M.; PAN-CHYR YANG ; Chen J.J.W.; Chang G.-C. | Oncotarget | 9 | 9 | |
9 | 2016 | Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition | Lin S.-Y.; Lee Y.-X.; SUNG-LIANG YU ; Chang G.-C.; Chen J.J.W. | Oncotarget | 7 | 7 | |
10 | 2015 | Identification of Five Driver Gene Mutations in Patients with Treatment-Naïve Lung Adenocarcinoma in Taiwan | Hsu K.-H.; CHAO-CHI HO ; Hsia T.-C.; Tseng J.-S.; KANG-YI SU ; Wu M.-F.; Chiu K.-L.; Yang T.-Y.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; SUNG-LIANG YU ; CHONG-JEN YU ; PAN-CHYR YANG ; Chang G.-C. | PLoS ONE | 98 | 92 | |
11 | 2015 | PARVA promotes metastasis by modulating ILK signalling pathway in lung adenocarcinoma | Huang A.-H.; SZU-HUA PAN ; Chang W.-H.; Hong Q.-S.; Chen J.J.W.; SUNG-LIANG YU | PLoS ONE | 24 | 24 | |
12 | 2015 | EGFR mutation and lobar location of lung adenocarcinoma | Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; CHAO-CHI HO ; Hsia T.-C.; KANG-YI SU ; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; SUNG-LIANG YU ; CHONG-JEN YU ; PAN-CHYR YANG ; Yang T.-Y.; Chang G.-C. | Carcinogenesis | 13 | 12 | |
13 | 2015 | R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability | Chen H.-Y.; SUNG-LIANG YU ; Ho B.-C.; KANG-YI SU ; Hsu Y.-C.; Chang C.-S.; Li Y.-C.; Yang S.-Y.; Hsu P.-Y.; Ho H.; Chang Y.-H.; Chen C.-Y.; Yang H.-I.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Yuan S.; Lee M.-H.; Liu C.-H.; Wu G.-I.; Hsiung C.A.; Chen Y.-M.; Wang C.-L.; Huang M.-S.; CHONG-JEN YU ; KUAN-YU CHEN ; Tsai Y.-H.; Su W.-C.; HUEI-WEN CHEN ; Chen J.J.W.; Chen C.-J.; Chang G.-C.; PAN-CHYR YANG ; Li K.-C. | Journal of Clinical Oncology | 76 | 71 | |
14 | 2015 | Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression | ANG YUAN ; Hsiao Y.-J.; Chen H.-Y.; HUEI-WEN CHEN ; CHAO-CHI HO ; Chen Y.-Y.; Liu Y.-C.; Hong T.-H.; SUNG-LIANG YU ; Chen J.J.W.; PAN-CHYR YANG | Scientific Reports | 258 | 229 | |
15 | 2015 | Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways | Lai Y.-H.; Chen M.-H.; Lin S.-Y.; Lin S.-Y.; Wong Y.-H.; SUNG-LIANG YU ; HUEI-WEN CHEN ; CHIH-HSIN YANG ; Chang G.-C.; Chen J.J.W. | Oncotarget | 10 | 8 | |
16 | 2015 | HOXA5 inhibits metastasis via regulating cytoskeletal remodelling and associates with prolonged survival in non-small-cell lung carcinoma | Wang C.-C.; KANG-YI SU ; Chen H.-Y.; Chang S.-Y.; Shen C.-F.; Hsieh C.-H.; Hong Q.-S.; Chiang C.-C.; Chang G.-C.; SUNG-LIANG YU ; Chen J.J.W. | PLoS ONE | 38 | 32 | |
17 | 2014 | Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancer | Chen C.-C.; Chen H.-Y.; KANG-YI SU ; Hong Q.-S.; BO-SHIUN YAN ; Chen C.-H.; SZU-HUA PAN ; YIH-LEONG CHANG ; Wang C.-J.; Hung P.-F.; Yuan S.; Chang G.-C.; Chen J.J.W.; PAN-CHYR YANG ; YA-CHIEN YANG ; SUNG-LIANG YU | American Journal of Respiratory and Critical Care Medicine | 30 | 33 | |
18 | 2012 | Comparative proteomic profiling of human lung adenocarcinoma cells (CL 1-0) expressing miR-372 | Lai J.-H.; She T.-F.; Juang Y.-M.; Tsay Y.-G.; Huang A.-H.; SUNG-LIANG YU ; Chen J.J.W.; Lai C.-C. | Electrophoresis | 18 | 16 | |
19 | 2012 | A novel function of YWHAZ/β-catenin axis in promoting epithelial-mesenchymal transition and lung cancer metastasis | Chen C.-H.; Chuang S.-M.; Yang M.-F.; Liao J.-W.; SUNG-LIANG YU ; Chen J.J.W. | Molecular Cancer Research | 77 | 78 | |
20 | 2012 | Single-walled carbon nanotubes induce airway hyperreactivity and parenchymal injury in mice | Hsieh W.-Y.; Chou C.-C.; CHAO-CHI HO ; SUNG-LIANG YU ; Chen H.-Y.; HAN-YI E. CHOU ; Chen J.J.W.; HUEI-WEN CHEN ; PAN-CHYR YANG | American Journal of Respiratory Cell and Molecular Biology | 31 | 27 | |
21 | 2011 | Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations | Yuan S.; SUNG-LIANG YU ; Chen H.-Y.; Hsu Y.-C.; KANG-YI SU ; HUEI-WEN CHEN ; Chen C.-Y.; CHONG-JEN YU ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; PAN-CHYR YANG | Journal of Clinical Oncology | 28 | 26 | |
22 | 2011 | Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E | Ho B.-C.; SUNG-LIANG YU ; Chen J.J.W.; SUI-YUAN CHANG ; BO-SHIUN YAN ; Hong Q.-S.; Singh S.; CHUAN-LIANG KAO ; Chen H.-Y.; KANG-YI SU ; Li K.-C.; Cheng C.-L.; Cheng H.-W.; Lee J.-Y.; Lee C.-N.; PAN-CHYR YANG | Cell Host and Microbe | 135 | 127 | |
23 | 2011 | Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: The versatile adjuvant for gefitinib therapy | Lee J.-Y.; Lee Y.-M.; Chang G.-C.; SUNG-LIANG YU ; Hsieh W.-Y.; Chen J.J.W.; HUEI-WEN CHEN ; PAN-CHYR YANG | PLoS ONE | 111 | 86 | |
24 | 2010 | Tumor suppressor HLJ1 binds and functionally alters nucleophosmin via activating enhancer binding protein 2α complex formation | Chang T.-P.; SUNG-LIANG YU ; Lin S.-Y.; Hsiao Y.-J.; Chang G.-C.; PAN-CHYR YANG ; Chen J.J.W. | Cancer Research | 20 | 21 | |
25 | 2010 | HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma | Lin S.-Y.; Hsueh C.-M.; SUNG-LIANG YU ; Su C.-C.; Shum W.-Y.; Yeh K.-C.; Chang G.-C.; Chen J.J.W. | Nucleic Acids Research | 27 | 25 | |
26 | 2008 | Intra-abdominal adhesion formation induces anti-oxidative injury, enhances cell proliferation, and prevents complement-mediated lysis | SUNG-LIANG YU ; Singh S.; HUEI-WEN CHEN ; Chen H.-Y.; Chen J.J.W.; WEN-JONE CHEN ; Chen H.-S.; SHYR-CHYR CHEN | Wound Repair and Regeneration | 5 | 4 | |
27 | 2008 | Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1 | HUEI-WEN CHEN ; Lee J.-Y.; Huang J.-Y.; Wang C.-C.; Chen W.-J.; SHENG-FANG SU ; Huang C.-W.; CHAO-CHI HO ; Chen J.J.W.; Tsai M.-F.; SUNG-LIANG YU ; PAN-CHYR YANG | Cancer Research | 210 | 194 | |
28 | 2008 | MicroRNA Signature Predicts Survival and Relapse in Lung Cancer | SUNG-LIANG YU ; HSUAN-YU CHEN; Chang G.-C.; Chen C.-Y.; HUEI-WEN CHEN ; Singh S.; Cheng C.-L.; CHONG-JEN YU ; Lee Y.-C.; Chen H.-S.; Su T.-J.; Chiang C.-C.; Li H.-N.; Hong Q.-S.; Su H.-Y.; Chen C.-C.; Chen, W.-J.; Liu C.-C.; Chan W.-K.; WEI J. CHEN ; Li K.-C.; Chen J.J.W.; PAN-CHYR YANG | Cancer Cell | 725 | 672 | |
29 | 2007 | Unique microRNA signature and clinical outcome of cancers | SUNG-LIANG YU ; Chen H.-Y.; PAN-CHYR YANG ; Chen J.J.W. | DNA and Cell Biology | 40 | 40 | |
30 | 2007 | A five-gene signature and clinical outcome in non-small-cell lung cancer | Chen H.-Y.; SUNG-LIANG YU ; Chen C.-H.; Chang G.-C.; Chen C.-Y.; ANG YUAN ; Cheng C.-L.; Wang C.-H.; Terng H.-J.; Kao S.-F.; Chan W.-K.; Li H.-N.; Liu C.-C.; Singh S.; WEI J. CHEN ; Chen J.J.W.; PAN-CHYR YANG | New England Journal of Medicine | 794 | 735 | |
31 | 2006 | Titanium dioxide nanoparticles induce emphysema-like lung injury in mice | HUEI-WEN CHEN ; SHENG-FANG SU ; Chien C.-T.; Lin W.-H.; SUNG-LIANG YU ; Chou C.-C.; Chen J.J.W.; PAN-CHYR YANG | FASEB Journal | 302 | 234 | |
32 | 2005 | Gene expression profiles in hypoxic preconditioning using cDNA microarray analysis: Altered expression of an angiogenic factor, carcinoembryonic antigen-related cell adhesion molecule 1 | WEN-JONE CHEN ; HUEI-WEN CHEN ; SUNG-LIANG YU ; CHIEN-HUA HUANG ; TZUNG-DAU WANG ; Chen J.J.W.; Chien C.-T.; Chen H.-Y.; PAN-CHYR YANG ; Lee Y.-T. | Shock | 39 | 37 | |
33 | 2004 | Anti-Invasive Gene Expression Profile of Curcumin in Lung Adenocarcinoma Based on a High Throughput Microarray Analysis | HUEI-WEN CHEN ; SUNG-LIANG YU ; Chen J.J.W.; Li H.-N.; Lin Y.-C.; Yao P.-L.; HAN-YI E. CHOU ; Chien C.-T.; WEN-JONE CHEN ; Lee Y.-T.; PAN-CHYR YANG | Molecular Pharmacology | 106 | 97 | |
34 | 2004 | Differential gene expression in gram-negative and gram-positive sepsis | SUNG-LIANG YU ; HUEI-WEN CHEN ; PAN-CHYR YANG ; Peck K.; Tsai M.-H.; Chen J.J.W.; Lin F.-Y. | American Journal of Respiratory and Critical Care Medicine | 69 | 55 | |
35 | 2004 | Dynamic changes of gene expression profiles during postnatal development of the heart in mice | HUEI-WEN CHEN ; SUNG-LIANG YU ; WEN-JONE CHEN ; PAN-CHYR YANG ; Chien C.-T.; HAN-YI E. CHOU ; Li H.-N.; Peck K.; CHIEN-HUA HUANG ; Lin F.-Y.; Chen J.J.W.; Lee Y.-T. | Heart | 41 | 38 |